Literature DB >> 30030473

Infant medulloblastoma - learning new lessons from old strata.

Marc Remke1,2,3, Vijay Ramaswamy4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30030473     DOI： 10.1038/s41571-018-0071-6

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  5 in total

1.  Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen.

Authors:  Lorena V Baroni; Claudia Sampor; Adriana Gonzalez; Fabiana Lubieniecki; Gabriela Lamas; Carlos Rugilo; Ute Bartels; Ayala Heled; Kyle S Smith; Paul A Northcott; Eric Bouffet; Daniel Alderete; Vijay Ramaswamy
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

Review 2.  Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.

Authors:  Han Zou; Brad Poore; Alberto Broniscer; Ian F Pollack; Baoli Hu
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

3.  Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir.

Authors:  Marieke Gringmuth; Jenny Walther; Sebastian Greiser; Magali Toussaint; Benjamin Schwalm; Marcel Kool; Rolf-Dieter Kortmann; Annegret Glasow; Ina Patties
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 4.  The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes.

Authors:  Nicholas Major; Neal A Patel; Josiah Bennett; Ena Novakovic; Dana Poloni; Mickey Abraham; Nolan J Brown; Julian L Gendreau; Ronald Sahyouni; Joshua Loya
Journal:  J Pers Med       Date:  2022-06-27

Review 5.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.